Monica M. Laronda, PhD, and Jane E. Reusch, MD, have long been leading advocates for the importance of equity in scientific research, specifically as it relates to women’s health. As they engage with national initiatives focusing on how this research is funded, they spoke to Endocrine News to discuss the latest in these efforts, their...
Measuring the circulating abundance of microRNAs is likely as effective as measuring the level of sugar in the blood for determining how a young person with type 2 diabetes will fare, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Jeanie Tryggestad, MD, an associate professor of...
Boys and girls may equally have multiple pituitary hormone deficiencies across all levels of peak growth hormone values, according to a study recently published in Clinical Endocrinology. The paper, by Rohan K. Henry, MD, MS, et al., outlines reported biases which have long been published regarding the male predominance in patients referred to pediatric endocrinology...
GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data presented at ENDO 2024. Researchers reviewed Medicare data documented from 2013 to 2020 and a large U.S. health insurance database from 2013 to 2022. They performed...
Neurocrine Biosciences, Inc. on July 1 announced the U.S. Food and Drug Administration (FDA) has accepted its two New Drug Applications (NDA) with Priority Review designations for crinecerfont in the treatment of children, adolescents, and adults with classic congenital adrenal hyperplasia (CAH). If approved, crinecerfont would be the first new treatment option for CAH in...
Exposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and pregnant women, especially among those with lower social and economic status, according to a study presented at ENDO 2024. The researchers focused this study on women who may be particularly...
As endocrinology fellowships go unfilled, leaders in the field are growing more concerned about the ability for endocrinology to meet the needs of future patients grappling with diabetes, obesity, and other endocrine disorders. To mitigate this potential gap, the Endocrine Society launched the Medical School Engagement Program (MSEP) to boost the interest of medical students...
Many of us are now fully back at our day job having returned from last month’s ENDO in Boston. The meeting was a fabulous success. There was such a buzz around the conference center, where friends and colleagues, old and new, met to discuss the very best in science and clinical practice. Congratulations and a...
Many of us are now fully back at our day job having returned from last month’s ENDO in Boston. The meeting was a fabulous success. There was such a buzz around the conference center, where friends and colleagues, old and new, met to discuss the very best in science and clinical practice. Congratulations and a...
